GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orphazyme AS (CHIX:ORPHAc) » Definitions » Other Stockholders Equity

Orphazyme AS (CHIX:ORPHAC) Other Stockholders Equity : kr-0.00 Mil (As of Jun. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Orphazyme AS Other Stockholders Equity?

Orphazyme AS's Other Stockholders Equity for the quarter that ended in Jun. 2022 was kr-0.00 Mil.

Orphazyme AS's quarterly Other Stockholders Equity increased from Jun. 2021 (kr-0.00 Mil) to Dec. 2021 (kr-0.00 Mil) and increased from Dec. 2021 (kr-0.00 Mil) to Jun. 2022 (kr-0.00 Mil).

Orphazyme AS's annual Other Stockholders Equity increased from Dec. 2019 (kr0.00 Mil) to Dec. 2020 (kr0.00 Mil) but then declined from Dec. 2020 (kr0.00 Mil) to Dec. 2021 (kr-0.00 Mil).

Orphazyme AS Other Stockholders Equity Historical Data

The historical data trend for Orphazyme AS's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orphazyme AS Other Stockholders Equity Chart

Orphazyme AS Annual Data
Trend Jun14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Other Stockholders Equity
Get a 7-Day Free Trial - - - - -

Orphazyme AS Quarterly Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.78 - - - -

Orphazyme AS Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Orphazyme AS Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Orphazyme AS's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Orphazyme AS (CHIX:ORPHAC) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orphazyme AS (CHIX:ORPHAc) » Definitions » Other Stockholders Equity
Comparable Companies
Traded in Other Exchanges
N/A
Address
Ole Maaloes Vej 3, Copenhagen, DNK, DK-2200
Website
https://www.orphazyme.com
Orphazyme AS is a late-stage biopharmaceutical company engaged in the development and commercialization of novel therapeutics for the treatment of neurodegenerative rare diseases. The company's lead candidate, Arimoclomol, is in development for severe orphan diseases: Niemann-Pick disease Type C (NPC), Amyotrophic Lateral Sclerosis (ALS), and Inclusion Body Myositis (IBM).

Orphazyme AS (CHIX:ORPHAC) Headlines

No Headlines